Trials / Completed
CompletedNCT06740864
40 Hz Transcranial Alternating Current Stimulation for Inducing Gamma Oscillations
Induction and Stabilization of Gamma Oscillations With 40 Hz Transcranial Alternating Current Stimulation in Healthy Elderly
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- The National Brain Mapping Laboratory (NBML) · Academic / Other
- Sex
- All
- Age
- 50 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
This study aims to compare the efficacy of different 40 Hz tACS protocols in entraining gamma oscillations, which are linked to various cognitive functions and play a significant role in cognitive impairments like Alzheimer's disease. Specifically, it examines the effects of 40 Hz tACS applied to frontal brain regions versus fronto-temporal regions on gamma oscillations and working memory in healthy elderly individuals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial alternating current stimulation | Transcranial alternating current will be delivered utilizing a Starstim 8-channel constant current, battery-powered electric stimulator (Neuroelectrics, Barcelona, Spain). Circular carbon rubber electrodes (2cm radius, 12,57 cm2) are used throughout the stimulation. |
| DEVICE | Transcranial alternating current stimulation | Transcranial alternating current will be delivered utilizing a Starstim 8-channel constant current, battery-powered electric stimulator (Neuroelectrics, Barcelona, Spain). Circular carbon rubber electrodes (2cm radius, 12,57 cm2) are used throughout the stimulation. |
| DEVICE | Sham Transcranial alternating current stimulation | Sham tACS will be applied by only ramping the current for 15 seconds up and 15 seconds down at the beginning and end of the stimulation respectively. |
Timeline
- Start date
- 2024-06-01
- Primary completion
- 2025-02-01
- Completion
- 2025-06-01
- First posted
- 2024-12-18
- Last updated
- 2026-03-18
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT06740864. Inclusion in this directory is not an endorsement.